Home News CAR-T Poised to Create ‘Paradigm Shift’ in Non-Hodgkin Lymphoma back to News
minute read
Since the approval of the first chimeric antigen receptor T-cell therapy, the research community has grappled with a crucial question: Is the modality appropriate for earlier use by patients with certain types of cancer?
Topics: Press Coverage
1665 North Aurora Court
2004
Aurora, CO 80045
720-848-0300
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.
